TALS News and Press, Talaris Therapeutics Inc. From 10/29/21

BOSTON, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. , (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain sev...

Company will share first clinical update on Phase 3 FREEDOM-1 study in living donor kidney transplant (LDKT) recipients Poster with additional data from Phase 2 study follow-up to be presented at ASN Talaris to host investor conference call on November 4, 2021, to discus...

Halvorsen's 13F portfolio value decreased marginally from $33.58B to $32.98B this quarter. The number of positions decreased from 94 to 88. Viking Global added FIGS Inc. & JD.com and increased Amazon.com & General Electric during the quarter. The top three positions are Am...

BOSTON and LOUISVILLE, Ky., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseas...

Gainers: SmileDirectClub (NASDAQ:SDC) +14%, Voyager Therapeutics (NASDAQ:VYGR) +13%, Owlet (NYSE:OWLT) +12%, Ontrak (NASDAQ:OTRK) +10%, Evaxion Biotech (NASDAQ:EVAX) +9%. Losers: 22nd Century XXII -15%, Absci (NASDAQ:ABSI) -12%, NeuroMetr...

BOSTON and LOUISVILLE, Ky., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune disease...

JuSun/iStock via Getty Images During the week ended June 25, 2021, Healthcare sector rose 2.01% and Healthcare Select Sector SPDR ETF (XLV) gained 1.58% compared to weekly gain of 2.82% of S&P 500 ETF. Leading the top gainers pack was Atossa Therapeutics (ATO...

Point Roberts, WA and Delta, BC - June 18, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Biotech and Mining. Today's stocks have been added to our lists of fr...

Halvorsen's 13F portfolio value decreased from $36.37B to $33.58B. The number of positions decreased from 96 to 94. Viking Global added Bank of America while reducing JPMorgan Chase and dropping Walt Disney. The top three positions are Microsoft, BridgeBio Pharma, and Fidelity Nat...

Talaris Therapeutics (TALS): Q1 GAAP EPS of -$1.30 beats by $0.49.Finished the first quarter of 2021 with $140.1 million in cash, cash equivalents, and marketable securities.Press Release For further details see: Talaris Therapeutics EPS beats by $0.49